RAND Review

January-February 2020

Published Jan 6, 2020

Cover: RAND Review

The cover story spotlights RAND research on America's fentanyl crisis — a poisoning outbreak unlike previous drug epidemics that will require innovative responses and significant resources to confront. A second feature explores new approaches to clinical guideline development — ones that consider the experiences of not only health care practitioners but also patients and caregivers. In this issue's Commentary column, terrorism expert Colin Clarke reflects on the threat of white supremacists in the United States. And the Giving column highlights Ann Korologos, whose recent $2 million estate gift has established the Ann Korologos Impact Award Endowment at RAND.

Topics

Document Details

Citation

Chicago Manual of Style

RAND Review: January-February 2020. Santa Monica, CA: RAND Corporation, 2020. https://www.rand.org/pubs/corporate_pubs/CP22-2020-01.html.
BibTeX RIS

This publication is part of the RAND corporate publication series. Corporate publications include program or department brochures, newsletters, pamphlets, and miscellaneous information about RAND or RAND's business units.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.